disease < diseases < disorder

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]

Ident.	Authors (with country if any)	Title
000003 (2020)	Charlotte Girard-Guyonvarc'H ; Michele Iudici	[Targeted therapies for connective tissue diseases and vasculitis].
000006 (2020)	Anna Jakubczyc ; Claus Neurohr	[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000075 (2020)	Anca D. Askanase [États-Unis] ; Leila Khalili [États-Unis] ; Jill P. Buyon [États-Unis]	Thoughts on COVID-19 and autoimmune diseases
000079 (2020)	Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]	Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000109 (2020)	Eric Toussirot [France]	The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition
000113 (2020)	José M. Carballido [Suisse] ; Camille Regairaz [Suisse] ; Celine Rauld [Suisse] ; Layla Raad [Suisse] ; Damien Picard [Suisse] ; Michael Kammüller [Suisse]	The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases
000197 (2020)	Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]	Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000206 (2020)	Christos Koutsianas ; Konstantinos Thomas ; Dimitrios Vassilopoulos	Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000244 (2020)	Przemysław Błyszczuk [Suisse, Pologne] ; Zoltan Szekanecz [Hongrie]	Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis
000266 (2020)	Jessica Vandenhaute [Belgique] ; Carine H. Wouters [Belgique] ; Patrick Matthys [Belgique]	Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome
000267 (2020)	Emanuele Nicastri ; Nicola Petrosillo ; Tommaso Ascoli Bartoli ; Luciana Lepore ; Annalisa Mondi ; Fabrizio Palmieri ; Gianpiero D Ffizi ; Luisa Marchioni ; Silvia Murachelli ; Giuseppe Ippolito ; Andrea Antinori	National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
000277 (2020)	Sergiu Pasca [Roumanie] ; Ancuta Jurj [Roumanie] ; Bobe Petrushev [Roumanie] ; Ciprian Tomuleasa [Roumanie] ; Daniela Matei [Roumanie]	MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases
000280 (2020)	Paramarjan Piranavan [États-Unis] ; Manjeet Bhamra [États-Unis] ; Andras Perl [États-Unis]	Metabolic Targets for Treatment of Autoimmune Diseases
000281 (2020)	Haihua Zhang [République populaire de Chine] ; Tao Wang [République populaire de Chine] ; Zhifa Han [République populaire de Chine] ; Guiyou Liu [République populaire de Chine]	Mendelian randomization study to evaluate the effects of interleukin-6 signaling on four neurodegenerative diseases.
000286 (2020)	Tiago Torres [Portugal] ; Luis Puig [Espagne]	Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
000296 (2020)	Mayan Gilboa [Israël] ; Gil Bornstein [Israël] ; Ilan Ben-Zvi [Israël] ; Chagai Grossman [Israël]	Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
000336 (2020)	Christophe Richez [France] ; Estibaliz Lazaro [France] ; Maël Lemoine [France] ; Marie-Elise Truchetet [France] ; Thierry Schaeverbeke [France]	Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
000361 (2020)	Kunihiko Umekita ; Akihiko Okayama	HTLV-1 Infection and Rheumatic Diseases
000372 (2020)	Michie Imamura ; Akihiro Mukaino ; Koutaro Takamatsu ; Hiroto Tsuboi ; Osamu Higuchi ; Hideki Nakamura ; Saori Abe ; Yukio Ando ; Hidenori Matsuo ; Tadashi Nakamura ; Takayuki Sumida ; Atsushi Kawakami ; Shunya Nakane	Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases
000395 (2020)	Mohsen Jari [Iran] ; Reza Shiari [Iran] ; Omid Salehpour [Iran] ; Khosro Rahmani [Iran]	Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis
000418 (2020)	Martin Michaud [France] ; Olivier Lidove [France] ; Boris Bienvenu [France] ; Laurent Chiche [France] ; Geoffrey Urbanski [France]	Effectiveness and tolerance of off-label use of tocilizumab in autoimmune diseases: A Multicenter Study.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "diseases" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "diseases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    diseases
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021